Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.
Kei MorioMichio ImamuraYoshiiku KawakamiYuki NakamuraMasahiro HatookaReona MorioHatsue FujinoTakashi NakaharaEisuke MurakamiTomokazu KawaokaMasataka TsugeAkira HiramatsuHiroshi AikataC Nelson HayesDaiki MikiHidenori OchiYoshio KatamuraKeiko AratakiTakashi MoriyaHiroyuki ItoKeiji TsujiHiroshi KohnoKoji WakiToru TamuraToshio NakamuraKazuaki Chayamanull nullPublished in: Journal of medical virology (2018)
Both older and younger patients respond similarly to DAA therapy. Advanced liver fibrosis affects the virological response to sofosbuvir-based therapy.